Bard Financial Services, Inc. Organon & Co. Transaction History

Bard Financial Services, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$23.31 - $28.61 $9,324 - $11,444	-400 Reduced 3.84%	10,010 $280,000
Q3 2022 Oct 26, 2022	SELL	$23.4 - $34.25 $19,656 - $28,770	-840 Reduced 7.47%	10,410 $244,000
Q2 2022 Jul 06, 2022	SELL	$31.66 - $38.9 $25,486 - $31,314	-805 Reduced 6.68%	11,250 $380,000
Q1 2022 Apr 13, 2022	BUY	$30.45 - $39.36 $53,287 - $68,880	1,750 Added 16.98%	12,055 $421,000
Q4 2021 Jan 24, 2022	BUY	$28.67 - $37.13 $17,345 - $22,463	605 Added 6.24%	10,305 $314,000
Q3 2021 Oct 15, 2021	SELL	$28.63 - $35.64 $5,010 - $6,237	-175 Reduced 1.77%	9,700 $318,000
Q2 2021 Jul 13, 2021	BUY	$28.45 - $38.0 $280,943 - $375,250	9,875 New	9,875 $299,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Bard Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Bard Financial Services, Inc. with notifications on news.